Toll Free: 1-888-928-9744
Toll Free: 1-888-928-9744
Published: Feb, 2018 | Pages:
90 | Publisher: Grand View Research
Industry: Pharmaceutical | Report Format: Electronic (PDF)
The global local anesthesia drugs market size is anticipated to reach USD 6.45 billion by 2025, according to a new report by Grand View Research, Inc., registering a 3.7% CAGR during the forecast period. Rising number of surgical procedures across the globe, including cosmetic surgeries, dental procedures, and plastic surgeries, is driving the growth of local anesthetics. There has been a considerable increase in number of surgical procedures requiring post-operative pain relief and this trend is expected to continue throughout the forecast period. Roughly, 65.0% of total surgical procedures require post-operative pain management. This is likely to boost the demand for local anesthesia drugs. Introduction of new and effective drugs such as levobupivacaine, articaine, and ropivacaine is also driving the growth of the local anesthesia drugs market across the globe. Rising healthcare expenditure in developing countries is expected to result in an increase in number of surgeries performed in countries such as India, China, and Brazil. This is likely to contribute to market growth in the region. Further key findings from the study suggest: • Lidocaine dominated the market by product as of 2016 owing to its extensive use as topical and injectable anesthetic • By application, the market is bifurcated into injectable and surface anesthetic. The injectable segment is expected to dominate the local anesthesia drugs market during the forecast period owing to extensive usage in different surgical procedures. Advancements in drug delivery systems is expected to drive the market for surface anesthetics over the forecast period • North America held the largest share in the market for local anesthesia drugs owing to significant number of surgical procedures performed in the region • Some of the key players are Aspen Pharmacare; Fresenius Kabi; Novartis, Inc.; Sagent Pharmaceutical; Pacira Pharmaceutical; Mylan; and Teva Pharmaceuticals.
Table of Contents
Chapter 1 Research Methodology & Scope
1.1 Information procurement
1.2 Data Analysis
1.3 Region Wise Market Calculation
1.3.1 Region Wise Market: Base Estimates
1.3.2 Global Market: CAGR Calculation
1.4 List of Secondary Sources
Chapter 2 Executive Summary
2.1 Market Snapshot
Chapter 3 Market Variables, Trends & Scope
3.1 Market Segmentation
3.2 Market Size and Growth Prospects
3.3 Local anesthesia drugs Market - Key Market Driver Analysis
3.3.2 Growing use of local anesthetic in post-operative pain
3.3.3 Introduction of new drugs and advancement in technologies
3.3.4 Growing geriatric population
3.4 Local anesthesia drugs - Key Market Restraint Analysis
3.4.1 Dose dependent side effects and limited duration of action
3.5 Key Opportunities Prioritized
3.6 Industry Analysis Porter's
3.7 Local anesthesia drugs PESTEL Analysis
Chapter 4 Local Anesthesia Drugs Market: Product Segment Estimates & Trend Analysis
4.1 Local anesthesia drugs market: Product movement analysis
4.1.1 Bupivacaine
4.1.1.1 Bupivacaine market, 2014 - 2025 (USD Million)
4.1.2 Ropivacaine
4.1.2.1 Ropivacaine market, 2014 - 2025 (USD Million)
4.1.3 Lidocaine
4.1.3.1 Lidocaine market, 2014 - 2025 (USD Million)
4.1.4 Chloroprocaine
4.1.4.1 Chloroprocaine market, 2014 - 2025 (USD Million)
4.1.5 Prilocaine
4.1.5.1 Prilocaine market, 2014 - 2025 (USD Million)
4.1.6 Benzocaine
4.1.6.1 Benzocaine market, 2014 - 2025 (USD Million)
4.1.7 Other Local Anesthetics
4.1.7.1 Other local anesthetics market, 2014 - 2025 (USD Million)
Chapter 5 Local Anesthesia Drugs Market: Application Segment Estimates & Trend Analysis
5.1 Local anesthesia drugs market: Application movement analysis
5.1.1 Injectable
5.1.1.1 Injectable anesthetic market, 2014 - 2025 (USD Million)
5.1.2 Surface Anesthetic
5.1.2.1 Surface anesthetic market, 2014 - 2025 (USD Million)
Chapter 6 Local Anesthesia Drugs Market: Regional Estimates & Trend Analysis
6.1 Local anesthesia drugs Market Share by Region, 2015 & 2025
6.2 North America
6.2.1 North America local anesthesia drugs market estimates and forecasts, 2014 - 2025
6.2.2 U.S.
6.2.2.1 U.S. local anesthesia drugs market estimates and forecasts, 2014 - 2025
6.2.3 Canada
6.2.3.1 Canada Local anesthesia drugs market estimates and forecasts, 2014 - 2025
6.3 Europe
6.3.1 Europe local anesthesia drugs market estimates and forecasts, 2014 - 2025
6.3.2 U.K.
6.3.2.1 U.K. local anesthesia drugs market estimates and forecasts, 2014 - 2025
6.3.3 Germany
6.3.3.1 Germany local anesthesia drugs market estimates and forecasts, 2014 - 2025
6.4 Asia Pacific
6.4.1 Asia Pacific local anesthesia drugs market estimates and forecasts, 2014 - 2025
6.4.2 Japan
6.4.2.1 Japan local anesthesia drugs market estimates and forecasts, 2014 - 2025
6.4.3 China
6.4.3.1 China local anesthesia drugs market estimates and forecasts, 2014 - 2025
6.5 Latin America
6.5.1 Latin America Local anesthesia drugs market estimates and forecasts, 2014 - 2025
6.5.2 Brazil
6.5.2.1 Brazil Local anesthesia drugs market estimates and forecasts, 2014 - 2025
6.5.3 Mexico
6.5.3.1 Mexico Local anesthesia drugs market estimates and forecasts, 2014 - 2025
6.6 MEA
6.6.1 MEA Local anesthesia drugs market estimates and forecasts, 2014 - 2025
6.6.2 South Africa
6.6.2.1 South Africa Local anesthesia drugs market estimates and forecasts, 2014 - 2025
Chapter 7 Competitive Landscape
7.1 Strategy framework
7.2 Company Profiles
7.2.1 Fresenius SE & Co. KGaA
7.2.1.1 Company overview
7.2.1.2 Financial performance
7.2.1.3 Product pipeline
7.2.1.4 Strategic initiatives
7.2.2 Aspen Pharmacare
7.2.2.1 Company overview
7.2.2.2 Financial performance
7.2.2.3 Product pipeline
7.2.2.4 Strategic initiatives
7.2.3 Pfizer Inc.
7.2.3.1 Company overview
7.2.3.2 Financial performance
7.2.3.3 Product benchmarking
7.2.3.4 Strategic initiatives
7.2.4 Sagent Pharmaceutical, Inc.
7.2.4.1 Company overview
7.2.4.2 Financial performance
7.2.4.3 Product pipeline
7.2.4.4 Strategic initiatives
7.2.5 Mylan
7.2.5.1 Company overview
7.2.5.2 Financial performance
7.2.5.3 Product benchmarking
7.2.5.4 Strategic initiatives
7.2.6 Pacira Pharmaceuticals, Inc.
7.2.6.1 Company overview
7.2.6.2 Financial performance
7.2.6.3 Product benchmarking
7.2.6.4 Strategic initiatives
7.2.7 Teva Pharmaceuticals
7.2.7.1 Company overview
7.2.7.2 Financial performance
7.2.7.3 Product benchmarking
7.2.7.4 Strategic initiatives
List of Tables Table 1 Country share estimation Table 2 List of market players Table 3 North America Local anesthesia drug market, by product, 2014 - 2025 (USD Million) Table 4 North America Local anesthesia drug market, by application, 2014' - 2025 (USD Million) Table 5 U.S. Local anesthesia drug market, by product, 2014 - 2025 (USD Million) Table 6 U.S. Local anesthesia drug market, by application, 2014 - 2025 (USD Million) Table 7 Canada Local anesthesia drug market, by product, 2014 - 2025 (USD Million) Table 8 Canada Local anesthesia drug market, by application, 2014 - 2025 (USD Million) Table 9 Europe Local anesthesia drug market, by product, 2014 - 2025 (USD Million) Table 10 Europe Local anesthesia drug market, by application, 2014 - 2025 (USD Million) Table 11 U.K. Local anesthesia drug market, by product, 2014 - 2025 (USD Million) Table 12 U.K. Local anesthesia drug market, by application, 2014 - 2025 (USD Million) Table 13 Germany Local anesthesia drug market, by product, 2014 - 2025 (USD Million) Table 14 Germany Local anesthesia drug market, by application, 2014 - 2025 (USD Million) Table 15 Asia Pacific Local anesthesia drug market, by product, 2014 - 2025 (USD Million) Table 16 Asia Pacific Local anesthesia drug market, by application, 2014 - 2025 (USD Million) Table 17 Japan Local anesthesia drug market, by product, 2014 - 2025 (USD Million) Table 18 Japan Local anesthesia drug market, by application, 2014 - 2025 (USD Million) Table 19 China Local anesthesia drug market, by product, 2014 - 2025 (USD Million) Table 20 China Local anesthesia drug market, by application, 2014 - 2025 (USD Million) Table 21 Latin America Local anesthesia drug market, by product, 2014 - 2025 (USD Million) Table 22 Latin America Local anesthesia drug market, by application, 2014 - 2025 (USD Million) Table 23 Brazil Local anesthesia drug market, by product, 2014 - 2025 (USD Million) Table 24 Brazil Local anesthesia drug market, by application, 2014 - 2025 (USD Million) Table 25 Mexico Local anesthesia drug market, by product, 2014 - 2025 (USD Million) Table 26 Mexico Local anesthesia drug market, by application, 2014 - 2025 (USD Million) Table 27 MEA Local anesthesia drug market, by product, 2014 - 2025 (USD Million) Table 28 MEA Local anesthesia drug market, by application, 2014 - 2025 (USD Million) Table 29 South Africa Local anesthesia drug market, by product, 2014 - 2025 (USD Million) Table 30 South Africa Local anesthesia drug market, by application, 2014 - 2025 (USD Million) List of Figures FIG. 1 Market research process FIG. 2 Information procurement FIG. 3 Primary research pattern FIG. 4 Market research approaches FIG. 5 Value chain based sizing & forecasting FIG. 6 QFD modeling for market share assessment FIG. 7 Market summary (Figures in USD Million, 2016) FIG. 8 Market trends & outlook FIG. 9 Local anesthesia drugs market: Market Segmentation FIG. 10 Local anesthesia drugs market revenue, (USD Million), 2014-2025 FIG. 11 Market driver relevance analysis (Current & future impact) FIG. 12 Global geriatric population, 2012 - 2022 (Million) FIG. 13 Market restraint relevance analysis (Current & future impact) FIG. 14 Key opportunities Prioritized FIG. 15 Local anesthesia drugs Porter's analysis FIG. 16 Local anesthesia drugs PESTEL analysis FIG. 17 Local anesthesia drugs market product outlook key takeaways FIG. 18 Local anesthesia drugs market: Type movement analysis FIG. 19 Bupivacaine market, 2014 - 2025 (USD Million) FIG. 20 Ropivacaine market, 2014 - 2025 (USD Million) FIG. 21 Lidocaine market, 2014 - 2025 (USD Million) FIG. 22 Chloroprocaine market, 2014 - 2025 (USD Million) FIG. 23 Neurological disorder market, 2014 - 2025 (USD Million) FIG. 24 Benzocaine market, 2014 - 2025 (USD Million) FIG. 25 Other local anesthetic market, 2014 - 2025 (USD Million) FIG. 26 Local anesthesia drugs market application outlook key takeaways FIG. 27 Local anesthesia drugs market: Application movement analysis FIG. 28 Injectable anesthetic market, 2014 - 2025 (USD Million) FIG. 29 Surface anesthetic market, 2014 - 2025 (USD Million) FIG. 30 Regional market place: Key takeaways FIG. 31 Regional outlook, 2015 & 2025 FIG. 32 North America local anesthesia drugs market, 2014 - 2025 (USD Million) FIG. 33 U.S. local anesthesia drugs market, 2014 - 2025 (USD Million) FIG. 34 Canada Local anesthesia drugs market, 2014 - 2025 (USD Million) FIG. 35 Europe Local anesthesia drugs market, 2014 - 2025 (USD Million) FIG. 36 U.K. local anesthesia drugs, 2014 - 2025 (USD Million) FIG. 37 Germany Local anesthesia drugs market, 2014 - 2025 (USD Million) FIG. 38 Asia Pacific local anesthesia drugs market, 2014 - 2025 (USD Million) FIG. 39 Japan local anesthesia drugs market, 2014 - 2025 (USD Million) FIG. 40 China local anesthesia drugs market, 2014 - 2025 (USD Million) FIG. 41 Latin America Local anesthesia drugs market, 2014 - 2025 (USD Million) FIG. 42 Brazil Local anesthesia drugs market, 2014 - 2025 (USD Million) FIG. 43 Mexico Local anesthesia drugs market, 2014 - 2025 (USD Million) FIG. 44 MEA Local anesthesia drugs market, 2014 - 2025 (USD Million) FIG. 45 South Africa Local anesthesia drugs market, 2014 - 2025 (USD Million) FIG. 46 Strategy framework
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.
